These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35924163)

  • 1. Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
    Chiu PKF; Lee EKC; Chan MTY; Chan WHC; Cheung MH; Lam MHC; Ma ESK; Poon DMC
    Front Oncol; 2022; 12():962958. PubMed ID: 35924163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
    Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():12-26. PubMed ID: 33860645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.
    Poon DM; Chan CK; Chan K; Chu WH; Kwong PW; Lam W; Law KS; Lee EK; Liu PL; Sze HC; Wong JH; Chan ES
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():27-38. PubMed ID: 33860644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
    Poon DM; Chan CK; Chan TW; Cheung FY; Kwong PW; Lee EK; Leung AK; Leung SY; Ma WK; So HS; Tam PC; Ho LY
    BJU Int; 2018 May; 121(5):703-715. PubMed ID: 29211320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
    Ma WK; Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Kwong PW
    BJU Int; 2019 Aug; 124(2):221-241. PubMed ID: 30653801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the management of advanced and metastatic renal cell carcinoma: joint consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
    Poon DMC; Chan CK; Chan K; Chu WH; Kwong PWK; Lam W; Law KS; Lee EKC; Liu PL; Sze HCK; Wong JHM; Chan ESY
    Hong Kong Med J; 2022 Dec; 28(6):475-481. PubMed ID: 35815480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.
    Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3(Suppl 3):48-54. PubMed ID: 33860643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
    Poon DMC; Tan GM; Chan K; Chan MTY; Chan TW; Kan RWM; Lam MHC; Leung CLH; Wong KCW; Kam KKH; Ng CF; Chiu PKF
    Front Oncol; 2024; 14():1345322. PubMed ID: 38357197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement.
    Leung WK; Ng SC; Chow DK; Lao WC; Leung VK; Li MK; Hui YT; Ng SS; Hui AJ; Lai ST; Lam JT; Poon JT; Chan AO; Yuen H; Wu JC; ;
    Hong Kong Med J; 2013 Feb; 19(1):61-8. PubMed ID: 23378357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of advanced prostate cancer in Hong Kong: Insights from an APCCC-Derived survey.
    Poon DM; Ma WK; Chan TW; Ho FK; Ho LY; Leung AK; Leung SY; Sze HC; Kwong PW; Chan ES
    Asia Pac J Clin Oncol; 2019 Oct; 15 Suppl 6():8-13. PubMed ID: 31642191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists.
    Kwong A; Cheng KD; Hsue CV; Hui SK; Leung CR; Leung KA; Ngan KR; Soong SI
    Asia Pac J Clin Oncol; 2019 Mar; 15 Suppl 2():20-31. PubMed ID: 30838787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.
    Mehra N; Kloots I; Vlaming M; Aluwini S; Dewulf E; Oprea-Lager DE; van der Poel H; Stoevelaar H; Yakar D; Bangma CH; Bekers E; van den Bergh R; Bergman AM; van den Berkmortel F; Boudewijns S; Dinjens WNM; Fütterer J; van der Hulle T; Jenster G; Kroeze LI; van Kruchten M; van Leenders G; van Leeuwen PJ; de Leng WWJ; van Moorselaar RJA; Noordzij W; Oldenburg RA; van Oort IM; Oving I; Schalken JA; Schoots IG; Schuuring E; Smeenk RJ; Vanneste BGL; Vegt E; Vis AN; de Vries K; Willemse PM; Wondergem M; Ausems M
    Eur Urol Open Sci; 2023 Mar; 49():23-31. PubMed ID: 36874601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.
    Shore ND; Drake CG; Lin DW; Ryan CJ; Stratton KL; Dunshee C; Karsh LI; Kaul S; Kernen K; Pieczonka C; Sieber P; Stewart C; Williams M; Concepcion RS
    Prostate; 2020 Oct; 80(14):1159-1176. PubMed ID: 32779781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance on the clinical understanding and use of long-acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements.
    Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Mak KY
    CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):5-11. PubMed ID: 33555614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
    Bratslavsky G; Mendhiratta N; Daneshvar M; Brugarolas J; Ball MW; Metwalli A; Nathanson KL; Pierorazio PM; Boris RS; Singer EA; Carlo MI; Daly MB; Henske EP; Hyatt C; Middleton L; Morris G; Jeong A; Narayan V; Rathmell WK; Vaishampayan U; Lee BH; Battle D; Hall MJ; Hafez K; Jewett MAS; Karamboulas C; Pal SK; Hakimi AA; Kutikov A; Iliopoulos O; Linehan WM; Jonasch E; Srinivasan R; Shuch B
    Cancer; 2021 Nov; 127(21):3957-3966. PubMed ID: 34343338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statements on the clinical uses of pregabalin for Hong Kong.
    Kwong PP; Chan EY; Cheung EY; Fong SY; Nip W; Cheung HH; Yip IP; Chong KY; Pao RS; Tam KL; Tang MH; Chan SK; Mak KY
    Asia Pac Psychiatry; 2020 Sep; 12(3):e12403. PubMed ID: 32830438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
    Lam TBL; MacLennan S; Willemse PM; Mason MD; Plass K; Shepherd R; Baanders R; Bangma CH; Bjartell A; Bossi A; Briers E; Briganti A; Buddingh KT; Catto JWF; Colecchia M; Cox BW; Cumberbatch MG; Davies J; Davis NF; De Santis M; Dell'Oglio P; Deschamps A; Donaldson JF; Egawa S; Fankhauser CD; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Gross T; Grummet JP; Henry AM; Ingels A; Irani J; Lardas M; Liew M; Lin DW; Moris L; Omar MI; Pang KH; Paterson CC; Renard-Penna R; Ribal MJ; Roobol MJ; Rouprêt M; Rouvière O; Sancho Pardo G; Richenberg J; Schoots IG; Sedelaar JPM; Stricker P; Tilki D; Vahr Lauridsen S; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; van Leenders GJLH; Varma M; Violette PD; Wallis CJD; Wiegel T; Wilkinson K; Zattoni F; N'Dow JMO; Van Poppel H; Cornford P; Mottet N
    Eur Urol; 2019 Dec; 76(6):790-813. PubMed ID: 31587989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong.
    Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Tam KL; Mak KY
    Intern Med J; 2020 Sep; 50 Suppl 3():6-14. PubMed ID: 32985093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus statements on adherence issues in schizophrenia for Hong Kong.
    Mak KY; Lo WT; Yeung WS; Wong M; Chung WS; Chui E; Tam KL; Hui LK; Mui J; Chan OW; Wong KL
    Asian J Psychiatr; 2014 Dec; 12():163-9. PubMed ID: 25440570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.